These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23686117)

  • 1. Tuberculosis: lights and shadows in the current diagnostic landscape.
    Norbis L; Miotto P; Alagna R; Cirillo DM
    New Microbiol; 2013 Apr; 36(2):111-20. PubMed ID: 23686117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TB diagnostic tests: how do we figure out their costs?
    Sohn H; Minion J; Albert H; Dheda K; Pai M
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):723-33. PubMed ID: 19681700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New diagnostics for latent and active tuberculosis: state of the art and future prospects.
    Pai M; O'Brien R
    Semin Respir Crit Care Med; 2008 Oct; 29(5):560-8. PubMed ID: 18810689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of tuberculosis and drug resistance: what can new tools bring us?
    Drobniewski F; Nikolayevskyy V; Balabanova Y; Bang D; Papaventsis D
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):860-70. PubMed ID: 22687497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.
    Perkins MD; Cunningham J
    J Infect Dis; 2007 Aug; 196 Suppl 1():S15-27. PubMed ID: 17624822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing landscape of diagnostic services for tuberculosis.
    Boehme CC; Saacks S; O'Brien RJ
    Semin Respir Crit Care Med; 2013 Feb; 34(1):17-31. PubMed ID: 23460003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in serodiagnosis of Mycobacterium tuberculosis infection.
    Abebe F; Holm-Hansen C; Wiker HG; Bjune G
    Scand J Immunol; 2007; 66(2-3):176-91. PubMed ID: 17635795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New diagnostic tools for tuberculosis.
    Perkins MD
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S182-8. PubMed ID: 11144551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New diagnostic tests for tuberculosis in southern countries: from theory to practice in southern countries].
    Bonnet M
    Rev Mal Respir; 2011 Dec; 28(10):1310-21. PubMed ID: 22152938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current developments and future perspectives for TB diagnostics.
    Palomino JC
    Future Microbiol; 2012 Jan; 7(1):59-71. PubMed ID: 22191447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.
    Lighter J; Rigaud M; Eduardo R; Peng CH; Pollack H
    Pediatrics; 2009 Jan; 123(1):30-7. PubMed ID: 19117857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting.
    Barth RE; Mudrikova T; Hoepelman AI
    Int J Infect Dis; 2008 Nov; 12(6):e1-6. PubMed ID: 18565778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
    Dowdy DW; O'Brien MA; Bishai D
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?
    Van Rie A; Page-Shipp L; Scott L; Sanne I; Stevens W
    Expert Rev Mol Diagn; 2010 Oct; 10(7):937-46. PubMed ID: 20964612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):423-32. PubMed ID: 16706744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.